Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
759,068
-
Shares change
-
-16,896
-
Total reported value, excl. options
-
$65,987,834
-
Value change
-
-$1,448,850
-
Number of buys
-
31
-
Number of sells
-
32
-
Price
-
$86.97
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q3 2024
As of 30 Sep 2024 INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) had 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 759,068 shares of stock of the company.
Largest 10 holders included Peak Asset Management, LLC, MORGAN STANLEY, LPL Financial LLC, BANK OF AMERICA CORP /DE/, Cambridge Investment Research Advisors, Inc., UBS Group AG, Federation des caisses Desjardins du Quebec, WELLS FARGO & COMPANY/MN, ENVESTNET ASSET MANAGEMENT INC, and MGB Wealth Management, LLC.
This table shows 97 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.